Filing Details

Accession Number:
0001181431-13-030733
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-05-24 16:45:54
Reporting Period:
2013-05-23
Filing Date:
2013-05-24
Accepted Time:
2013-05-24 16:45:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1017491 Apricus Biosciences Inc. APRI Pharmaceutical Preparations (2834) 870449967
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1328822 Robert Steven Martin 11975 El Camino Real, Suite 300
San Diego CA 92130
Senior Vp & Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-05-23 20,000 $2.85 20,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Warrant Acquisiton 2013-05-23 20,000 $2.85 10,000 $3.40
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
20,000 2013-05-29 2018-05-29 No 4 P Direct
Footnotes
  1. Purchase in accordance with the Underwriting Agreement, by and between Apricus Biosciences, Inc. and Lazard Capital Markets LLC, dated May 23, 2013.
  2. Each warrant is exercisable for 0.50 shares of common stock.